전일 마감가:
$2.21
열려 있는:
$2.23
하루 거래량:
58,454
Relative Volume:
0.46
시가총액:
$114.52M
수익:
$14.18M
순이익/손실:
$-82.66M
주가수익비율:
-1.6885
EPS:
-1.3
순현금흐름:
$-50.80M
1주 성능:
-3.10%
1개월 성능:
+6.83%
6개월 성능:
+9.50%
1년 성능:
+10.61%
시어 Stock (SEER) Company Profile
명칭
Seer Inc
전화
650-453-0000
주소
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
SEER을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
SEER
Seer Inc
|
2.19 | 124.51M | 14.18M | -82.66M | -50.80M | -1.30 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
408.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.13 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
시어 Stock (SEER) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-07-05 | 재개 | JP Morgan | Neutral |
2023-01-04 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2022-08-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2021-10-15 | 재개 | Cowen | Outperform |
2020-12-29 | 개시 | BofA Securities | Neutral |
2020-12-29 | 개시 | Cowen | Outperform |
2020-12-29 | 개시 | JP Morgan | Overweight |
2020-12-29 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
시어 주식(SEER)의 최신 뉴스
Using Bollinger Bands to evaluate Seer Inc.Market Performance Summary & Growth Focused Entry Reports - newser.com
Will Seer Inc. price bounce be sustainable2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Does Seer Inc. stock trade at a discount to peersWeekly Trend Report & Capital Efficiency Focused Strategies - newser.com
Is Seer Inc. stock a smart buy before Fed meetingJuly 2025 Patterns & Intraday High Probability Setup Alerts - newser.com
Can Seer Inc. stock hit record highs againWeekly Market Outlook & Technical Confirmation Trade Alerts - newser.com
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics 2025 - Investing News Network
Seer to showcase proteomics platform at ASHG 2025 annual meeting By Investing.com - Investing.com Nigeria
Seer to showcase proteomics platform at ASHG 2025 annual meeting - Investing.com
Seer, Inc. to Showcase Proteomic Innovations at ASHG 2025 Annual Meeting - Quiver Quantitative
Seer Highlights How Proteomics Complements Genomics to - GlobeNewswire
CoLab Oct 16 — Seer’s Proteograph Drives Proteogenomic Insights at ASHG 2025 (Oct 14–18) - Stock Titan
What indicators show strength in Seer Inc.Share Buyback & High Accuracy Trade Alerts - newser.com
Seer's (SEER) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Smart tools for monitoring Seer Inc.’s price actionTrade Volume Summary & Growth Focused Entry Point Reports - newser.com
Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study With Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults - 富途牛牛
Using Ichimoku Cloud for Seer Inc. technicalsPortfolio Update Report & Weekly Setup with ROI Potential - newser.com
Analyzing Seer Inc. with risk reward ratio charts2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
What analysts say about Seer Inc stockInstitutional Buying Trends & Superior Trading Ideas - earlytimes.in
Has Seer Inc. formed a bullish divergence2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
Heatmap analysis for Seer Inc. and competitors2025 Pullback Review & Stock Portfolio Risk Management - newser.com
Seer, Inc.(NasdaqGS: SEER) dropped from S&P Global BMI Index - MarketScreener
Fund Flows: Can Seer Inc be recession proofShare Buyback & AI Enhanced Trading Signals - خودرو بانک
Visual trend scoring systems applied to Seer Inc.Portfolio Value Report & Free Accurate Trade Setup Notifications - newser.com
Is Seer Inc. reversing from oversold territoryJuly 2025 Spike Watch & Daily Oversold Bounce Ideas - newser.com
시어 (SEER) 재무 분석
매출
순이익
현금흐름
주당 순 이익
시어 주식 (SEER) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Farokhzad Omid | CEO AND CHAIR |
Aug 20 '25 |
Sale |
2.04 |
33,992 |
69,483 |
1,272,068 |
Nishar Dipchand | Director |
Jun 13 '25 |
Sale |
2.08 |
30,253 |
62,935 |
49,204 |
자본화:
|
볼륨(24시간):